Pharmacotherapy for Obesity Should Begin in Primary Care

Smart Ring Outperforms Apple Watch for Atrial Fibrillation Detection

News

Video

Video: Obesity expert Dr Louis Aronne outlines the role of medication in obesity treatment and says primary care is absolutely the place to begin.

Video Player is loading.

Current Time 0:00

Duration 24:17

Loaded: 0%

Stream Type LIVE

Remaining Time 24:17

Louis J Aronne, MD

Director of the Comprehensive Weight Control Center, the Sanford I. Weill Professor of Metabolic Research, Professor of Clinical Medicine at Weill Cornell Medicine

Resources

Intellihealth

Baer HJ, Rozenblum R, De La Cruz BA, et al. Effect of an online weight management program integrated with population health management on weight change. JAMA. 2020;324:1737-1746. doi:10.1001/jama.2020.18977

Related Content

April 21st 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

The CART ring was superior to the Apple Watch in automated AF detection with fewer unclassified ECGs, but neither device should serve as a definitive diagnostic tool.

August 30th 2023

Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

April 15th 2025

Obesity & Type 2 Diabetes: An Expert Discussion

Following a Mediterranean-style diet and a prescribed regimen of physical activity was significantly protective of BMD, particularly at the lumbar level, over 3 years.

June 30th 2023

Tirzepatide Improves Heart Failure Symptoms and Renal Function in People with Obesity, CKD

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Novel Non-Invasive Glucose Monitor Uses Light-Based Technology

ACC 2025. Tirzepatide improved HF symptoms and renal function in patients with obesity-related HFpEF, regardless of CKD status, according to new findings from the SUMMIT trial.

Todd Shryock

Smart Ring Outperforms Apple Watch for Atrial Fibrillation Detection

Accuracy of data recorded with the GlucoBeam was found to be comparable to standard finger-stick blood glucose tests.

Related Content

April 21st 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

The CART ring was superior to the Apple Watch in automated AF detection with fewer unclassified ECGs, but neither device should serve as a definitive diagnostic tool.

August 30th 2023

Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

April 15th 2025

Obesity & Type 2 Diabetes: An Expert Discussion

Following a Mediterranean-style diet and a prescribed regimen of physical activity was significantly protective of BMD, particularly at the lumbar level, over 3 years.

June 30th 2023

Tirzepatide Improves Heart Failure Symptoms and Renal Function in People with Obesity, CKD

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Novel Non-Invasive Glucose Monitor Uses Light-Based Technology

ACC 2025. Tirzepatide improved HF symptoms and renal function in patients with obesity-related HFpEF, regardless of CKD status, according to new findings from the SUMMIT trial.

Todd Shryock